Log in to save to my catalogue

Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 m...

Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 m...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7441014

Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release

About this item

Full title

Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Psychopharmacology, 2020-11, Vol.237 (11), p.3497-3501

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Alternative Titles

Full title

Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7441014

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7441014

Other Identifiers

ISSN

0033-3158,1432-2072

E-ISSN

1432-2072

DOI

10.1007/s00213-020-05644-3

How to access this item